NCT05801757View on ClinicalTrials.gov

Continuous Infusion of Remidazolam for Colonoscopic Polypectomy in Elderly Patients

NACompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2024

Conditions
Colon Disease
Interventions
DRUG

Remimazolam

Using two different doses of remidazolam for continuous pumping to maintain anesthetic effect

DRUG

Propofol

propofol 2-3mg/kg/h

Trial Locations (1)

430000

Tongji Hospital, Wuhan

All Listed Sponsors
lead

Tongji Hospital

OTHER

NCT05801757 - Continuous Infusion of Remidazolam for Colonoscopic Polypectomy in Elderly Patients | Biotech Hunter | Biotech Hunter